BREEZY STANLEY: Open Payments
NPI 1932711389 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 33 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $977 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $235 |
| GENZYME CORPORATION | 5 | $151 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| Viatris Specialty LLC | 3 | $58 |
| Actelion Pharmaceuticals US, Inc. | 2 | $46 |
| Kestra Medical Technology Services, Inc. | 1 | $41 |
| Baxter Healthcare | 2 | $39 |
| Insmed, Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Resmed Corp | 1 | $26 |
Products named: DUPIXENT, BREZTRI, FASENRA, YUPELRI, AIRSUPRA, Assure WCD, Hillrom - Vest System Model 105 Home Care, TEZSPIRE.
Industry payments across MO — which companies pay providers there.
